Stansky Michael P
- SEC CIK
- 0001424204
In the past year, 2 open-market purchase filings worth $3.01M and no sales.
Current role at each company
- TLSI TriSalus Life Sciences, Inc.Directoras of May 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $3.01M
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$3.01M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Stansky Michael P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 (view filing) | May 15 | 3 days | Stansky Michael PDirector | PPurchase | +410.0K | $2.50 | +$1.02M | +49.4%1.24M after | |
| May 18, 2026 (view filing) | May 15 | 3 days | Stansky Michael PDirector | PPurchase | +200.0K | $2.50 | +$500.0K | +100.2%399.7K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Stansky Michael PDirector | PPurchase | +243.9K | $4.10 | +$1.00M | +44.9%787.1K after | |
| Feb 23, 2026 (view filing) | Feb 23 | Same day | Stansky Michael PDirector | PPurchase | +117.2K | $4.10 | +$480.5K | +142.1%199.7K after |